Mitomycin
In the US, Mitomycin (mitomycin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Bladder Cancer, Pancreatic Cancer and Stomach Cancer.
US matches:
UK matches:
- MITOMYCIN-C KYOWA 10 MG POWDER FOR SOLUTION FOR INJECTION (Leaflet)
- MITOMYCIN-C KYOWA 2 MG POWDER FOR SOLUTION FOR INJECTION (Leaflet)
- MITOMYCIN-C KYOWA 20MG POWDER FOR SOLUTION FOR INJECTION (Leaflet)
- MITOMYCIN-C KYOWA 40MG POWDER FOR SOLUTION FOR INJECTION (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01DC03
CAS registry number (Chemical Abstracts Service)
0000050-07-7
Chemical Formula
C15-H18-N4-O5
Molecular Weight
334
Therapeutic Category
Antineoplastic antibacterial
Chemical Names
[(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-ylmethyl]carbamate (IUPAC)
6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazarino[2',3':3,4]pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) (WHO)
Foreign Names
- Mitomycinum (Latin)
- Mitomycin (German)
- Mitomycine (French)
- Mitomicina (Spanish)
Generic Names
- Mitomicina (OS: DCIT)
- Mitomycin (OS: USAN, BAN)
- Mitomycine (OS: DCF)
- MIT-C (IS)
- Mitomycin (PH: BP 2011, Ph. Eur. 7, USP 34)
- Mitomycin C (PH: JP XV)
- Mitomycine C (PH: Ph. Franç. X)
- Mitomycinum (PH: Ph. Eur. 7)
Brand Names
- Almito
Alkem, India - Amétycine
Biosyn, Germany; Sanofi Aventis, Tunisia; Sanofi-Aventis, France - Asomutan
Raffo, Argentina - Crisofimina
Teva, Argentina - Kyowa Mitomycin-C
Kyowa Hakko Kirin, Philippines - Mitem
Curasan, Germany - Mitocin
Bristol-Myers Squibb, Brazil; Cadila, India; Korea United Pharm, Georgia - Mitocyna
Richmond, Argentina - Mito-extra
medac, Germany - Mitokebir
Aspen, Argentina - Mito-medac
medac, Germany - Mitomicina C Dosa
Dosa, Argentina - Mitomicina C Filaxis
Filaxis, Argentina - Mitomicina C Kyowa
Kyowa, Myanmar - Mitomicina C Sandoz
Sandoz, Argentina - Mitomicina Delta Farma
Delta Farma, Argentina - Mitomicina Kampar
Kampar, Chile - Mitomicina Martian
LKM, Argentina - Mitomicina Microsules
Microsules, Argentina - Mitomicina Rontag
Rontag, Argentina - Mitomicina
Palmagyar, Peru; Refasa, Peru - Mitomycin - Hisun
Hisun, China - Mitomycin Accord Healthcare
Accord Healthcare, United States - Mitomycin Baxter
Baxter, United States - Mitomycin Bedford
Bedford, United States - Mitomycin C - New Asiatic
New Asiatic Pharm, China - Mitomycin C Kyowa
Bristol-Myers Squibb, New Zealand - Mitomycin C
Arrow, New Zealand; Inibsa, Spain; Kyowa, Israel; Kyowa, Italy; Kyowa, Poland - Mitomycin HEXAL
Hexal, Germany - Mitomycin medac
medac, Germany - Mitomycin
Medac, Sweden - Mitomycin-C Kyowa
Bristol-Myers Squibb, Australia; Choong Wae, South Korea; Ebewe, Austria; Kyowa, Czech Republic; Kyowa, United Kingdom; Kyowa, Hungary; Kyowa, Malaysia; Kyowa Hakko, Hong Kong; Kyowa Hakko, Indonesia; Kyowa Hakko, Singapore; Kyowa Hakko Kirin, Bulgaria; Kyowa Hakko Kirin, Thailand; Kyowa Hakko Kirin Co., Ltd., Vietnam; Nycomed, Netherlands; Onko-Koçsel, Turkey - Mitomycin-C
Kuai Kuai, Taiwan - Mitomycine-C
Nycomed, Belgium - Mitomycin-Kirin Kunpeng
Kirin Kunpeng, China - Mitonovag
Gobbi, Argentina - Mitosol
Mobius Therapeutics, United States - Mitostat
Orion, Finland - Mitotie
Bioprofarma, Argentina - Mitotie (Mitomycin and Mannitol)
Bagó, Ecuador - Mytoxid
Korea United Pharma, Philippines - Sintemicina
Sintesina, Argentina - Urocin
Apogepha, Germany - Vetio
Ivax, Argentina
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
